Table 5.
- | Outcome Events | Threshold | AUC | 95% CI | Sensitivity, % | Specificity, % | P |
---|---|---|---|---|---|---|---|
Baseline PNR | END | 33.1 | 0.503 | 0.421-0.584 | 72.0% | 42.7% | 0.949 |
HT | 46.4 | 0.587 | 0.525-0.649 | 34.1% | 86.6% | 0.011 | |
DND | 22.2 | 0.592 | 0.461-0.724 | 86.0% | 60.0% | 0.118 | |
Poor 3-month outcome | 49.6 | 0.535 | 0.485-0.585 | 29.9% | 78.4% | 0.169 | |
Post-IVT PNR | END | 37.9 | 0.647 | 0.572-0.723 | 50.8% | 24.0% | 0.010 |
HT | 35.6 | 0.647 | 0.584-0.710 | 59.7% | 30.5% | <0.001 | |
DND | 26.8 | 0.762 | 0.637-0.887 | 79.3% | 72.0% | <0.001 | |
Poor 3-month outcome | 30.8 | 0.705 | 0.660-0.751 | 76.0% | 55.8% | <0.001 |
Abbreviations: PNR, Platelet-to-Neutrophil Ratio; IVT, Intravenous Thrombolysis; END, Early Neurologic Deterioration; HT, Hemorrhagic Transformation; DND, Delayed Neurological Deterioration.